Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The safety and tolerability of cariprazine in long-term treatment of schizophrenia: a post hoc pooled analysis
Henry A. Nasrallah, Willie Earley, Andrew J. Cutler, et al.
BMC Psychiatry (2017) Vol. 17, Iss. 1
Open Access | Times Cited: 73

Showing 1-25 of 73 citing articles:

Females with ADHD: An expert consensus statement taking a lifespan approach providing guidance for the identification and treatment of attention-deficit/ hyperactivity disorder in girls and women
Susan Young, Nicoletta Adamo, Bryndís Björk Ásgeirsdóttir, et al.
BMC Psychiatry (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 293
Long-term safety and tolerability of cariprazine as adjunctive therapy in major depressive disorder
Eduard Vieta, Willie Earley, Maria Victoria Burgess, et al.
International Clinical Psychopharmacology (2018) Vol. 34, Iss. 2, pp. 76-83
Open Access | Times Cited: 182
Cariprazine, A Broad-Spectrum Antipsychotic for the Treatment of Schizophrenia: Pharmacology, Efficacy, and Safety
I. Laszlovszky, Ágota Barabássy, György Németh
Advances in Therapy (2021) Vol. 38, Iss. 7, pp. 3652-3673
Open Access | Times Cited: 59
New and emerging treatments for schizophrenia: a narrative review of their pharmacology, efficacy and side effect profile relative to established antipsychotics
Maria Lobo, Thomas Whitehurst, Stephen Kaar, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 132, pp. 324-361
Open Access | Times Cited: 57
Efficacy of xanomeline and trospium chloride in schizophrenia: pooled results from three 5-week, randomized, double-blind, placebo-controlled, EMERGENT trials
Inder Kaul, Sharon Sawchak, Amy Claxton, et al.
Schizophrenia (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 7
The role of dopamine D3receptors in the mechanism of action of cariprazine
Francesca Calabrese, Frank I. Tarazi, Giorgio Racagni, et al.
CNS Spectrums (2019) Vol. 25, Iss. 3, pp. 343-351
Open Access | Times Cited: 52
Up-to-date expert opinion on the safety of recently developed antipsychotics
Laura Orsolini, Domenico De Berardis, Umberto Volpe
Expert Opinion on Drug Safety (2020) Vol. 19, Iss. 8, pp. 981-998
Closed Access | Times Cited: 48
Medication-Induced Akathisia with Newly Approved Antipsychotics in Patients with a Severe Mental Illness: A Systematic Review and Meta-Analysis
Koen Demyttenaere, Johan Detraux, Giorgio Racagni, et al.
CNS Drugs (2019) Vol. 33, Iss. 6, pp. 549-566
Open Access | Times Cited: 44
Treating schizophrenia with cariprazine: from clinical research to clinical practice. Real world experiences and recommendations from an International Panel
Andrea Fagiolini, J.Á. Cuesta Alcalá, Thomas Aubel, et al.
Annals of General Psychiatry (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 43
Safety and Tolerability of Cariprazine in Patients with Schizophrenia: A Pooled Analysis of Eight Phase II/III Studies
Ágota Barabássy, B. Sebe, K. Acsai, et al.
Neuropsychiatric Disease and Treatment (2021) Vol. Volume 17, pp. 957-970
Open Access | Times Cited: 38
New Antipsychotic Medications in the Last Decade
Mehak Pahwa, Ahmad Sleem, Omar H. Elsayed, et al.
Current Psychiatry Reports (2021) Vol. 23, Iss. 12
Closed Access | Times Cited: 35
Cariprazine Add-on in Inadequate Clozapine Response: A Report on Two Cases
Domenico De Berardis, Gabriella Rapini, Luigi Olivieri, et al.
Clinical Psychopharmacology and Neuroscience (2021) Vol. 19, Iss. 1, pp. 174-178
Open Access | Times Cited: 33
Physical illness in schizophrenia and the role of tolerability in antipsychotic selection: an expert consensus with a focus on cariprazine
Alessandro Cuomo, Giovanni B. Forleo, Taieb Ghodhbane, et al.
Annals of General Psychiatry (2025) Vol. 24, Iss. 1
Open Access
Cariprazine for acute and maintenance treatment of adults with schizophrenia: an evidence-based review and place in therapy
Leslie Citrome
Neuropsychiatric Disease and Treatment (2018) Vol. Volume 14, pp. 2563-2577
Open Access | Times Cited: 42
Management Strategies for Antipsychotic-Related Sexual Dysfunction: A Clinical Approach
Ángel L. Montejo, Rubén de Alarcón, N. Prieto, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 2, pp. 308-308
Open Access | Times Cited: 27
Impact of cariprazine on body weight and blood pressure among adults with bipolar I disorder, schizophrenia, or major depressive disorder in a real-world setting
Christoph U. Correll, Andrew J. Cutler, François Laliberté, et al.
Annals of General Psychiatry (2025) Vol. 24, Iss. 1
Open Access
Schizophrenia and Related Psychoses

(2025), pp. 1-278
Closed Access
Effect of Brexpiprazole on Prolactin
Jelena Ivkovic, Annika Lindstén, Vinu George, et al.
Journal of Clinical Psychopharmacology (2018) Vol. 39, Iss. 1, pp. 13-19
Open Access | Times Cited: 33
The effectiveness and safety of cariprazine in schizophrenia patients with negative symptoms and insufficient effectiveness of previous antipsychotic therapy: an observational study
Elmārs Rancāns, Z.B. Dombi, Péter Mátrai, et al.
International Clinical Psychopharmacology (2021) Vol. 36, Iss. 3, pp. 154-161
Open Access | Times Cited: 25
A review on the pharmacology of cariprazine and its role in the treatment of negative symptoms of schizophrenia
Panneer Selvan, Prashant Devkare, Arthik Shetty, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 3
Experiences of Minority Stress and Mental Health Burdens of Newly Arrived LGBTQ* Refugees in Germany
Jasmine Golembe, Birgit Leyendecker, N. Maalej, et al.
Sexuality Research and Social Policy (2020) Vol. 18, Iss. 4, pp. 1049-1059
Open Access | Times Cited: 24
Cariprazine Safety in Adolescents and the Elderly: Analyses of Clinical Study Data
B. Szatmári, Ágota Barabássy, Judit Harsányi, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 21
Does Psychological Capital Mediate Between Workplace Violence and Depressive Symptoms Among Doctors and Nurses in Chinese General Hospitals?
Xiaomeng Li, Huazhang Wu
Psychology Research and Behavior Management (2021) Vol. Volume 14, pp. 199-206
Open Access | Times Cited: 20
Cariprazine alleviates core behavioral deficits in the prenatal valproic acid exposure model of autism spectrum disorder
Viktor Román, Nika Adham, Andrew Foley, et al.
Psychopharmacology (2021) Vol. 238, Iss. 9, pp. 2381-2392
Open Access | Times Cited: 20
Cariprazine for Treating Schizophrenia, Mania, Bipolar Depression, and Unipolar Depression: A Review of Its Efficacy
Martin Tarzian, Mariana Ndrio, Srujan Kaja, et al.
Cureus (2023)
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top